BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heymann D. Metastatic osteosarcoma challenged by regorafenib. Lancet Oncol 2019;20:12-4. [PMID: 30477938 DOI: 10.1016/S1470-2045(18)30821-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Tirtei E, Campello A, Asaftei SD, Mareschi K, Cereda M, Fagioli F. Precision Medicine in Osteosarcoma: MATCH Trial and Beyond. Cells 2021;10:281. [PMID: 33572496 DOI: 10.3390/cells10020281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen M, Zhou L, Liao Z, Ye X, Xuan X, Gu B, Lu F. Sevoflurane Inhibited Osteosarcoma Cell Proliferation And Invasion Via Targeting miR-203/WNT2B/Wnt/β-Catenin Axis. Cancer Manag Res 2019;11:9505-15. [PMID: 31814757 DOI: 10.2147/CMAR.S225911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yin J, Pan S, Guo X, Gao Y, Zhu D, Yang Q, Gao J, Zhang C, Chen Y. Nb2C MXene-Functionalized Scaffolds Enables Osteosarcoma Phototherapy and Angiogenesis/Osteogenesis of Bone Defects. Nanomicro Lett 2021;13:30. [PMID: 34138204 DOI: 10.1007/s40820-020-00547-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jiang J, Wang W, Xiang W, Jiang L, Zhou Q. The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress. Bioengineered 2021. [PMID: 34720036 DOI: 10.1080/21655979.2021.1999372] [Reference Citation Analysis]
5 Meng X, Zhang Z, Chen L, Wang X, Zhang Q, Liu S. Silencing of the Long Non-Coding RNA TTN-AS1 Attenuates the Malignant Progression of Osteosarcoma Cells by Regulating the miR-16-1-3p/TFAP4 Axis. Front Oncol 2021;11:652835. [PMID: 34141611 DOI: 10.3389/fonc.2021.652835] [Reference Citation Analysis]
6 Wu H, He Y, Chen H, Liu Y, Wei B, Chen G, Lin H, Lin H. LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio 2019;9:781-90. [PMID: 30984551 DOI: 10.1002/2211-5463.12620] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
7 Liu W, Dong S, Hu W, Gao M, Li T, Ji Q, Yang X, Qi D, Zhang Z, Song Z, Liu Y, Zhang X. A simple, universal and multifunctional template agent for personalized treatment of bone tumors. Bioactive Materials 2022;12:292-302. [DOI: 10.1016/j.bioactmat.2021.10.027] [Reference Citation Analysis]
8 Qin Z, Luo K, Liu Y, Liao S, He J, He M, Xie T, Jiang X, Li B, Liu H, Huang Q, Tang H, Feng W, Zhan X. ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing. IJGM 2022;Volume 15:1033-45. [DOI: 10.2147/ijgm.s341879] [Reference Citation Analysis]
9 Alvarez C, Monasterio G, Cavalla F, Córdova LA, Hernández M, Heymann D, Garlet GP, Sorsa T, Pärnänen P, Lee HM, Golub LM, Vernal R, Kantarci A. Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms. Front Immunol 2019;10:1664. [PMID: 31379856 DOI: 10.3389/fimmu.2019.01664] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]